A detailed history of Cpwm, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Cpwm, LLC holds 18,411 shares of NVO stock, worth $2.42 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
18,411
Previous 18,883 2.5%
Holding current value
$2.42 Million
Previous $2.1 Million 12.83%
% of portfolio
0.17%
Previous 0.19%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $44,972 - $55,190
-472 Reduced 2.5%
18,411 $1.83 Million
Q2 2022

Aug 12, 2022

SELL
$103.24 - $121.81 $328,819 - $387,964
-3,185 Reduced 14.43%
18,883 $2.1 Million
Q1 2022

May 13, 2022

SELL
$93.1 - $112.54 $175,400 - $212,025
-1,884 Reduced 7.87%
22,068 $2.45 Million
Q3 2021

Nov 12, 2021

SELL
$84.42 - $106.62 $249,967 - $315,701
-2,961 Reduced 11.0%
23,952 $2.3 Million
Q2 2021

Aug 13, 2021

SELL
$67.66 - $84.76 $4,871 - $6,102
-72 Reduced 0.27%
26,913 $2.26 Million
Q1 2021

May 14, 2021

SELL
$67.06 - $75.82 $167,515 - $189,398
-2,498 Reduced 8.47%
26,985 $1.82 Million
Q4 2020

Feb 12, 2021

SELL
$63.89 - $73.8 $12,969 - $14,981
-203 Reduced 0.68%
29,483 $2.06 Million
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $147,888 - $163,050
-2,322 Reduced 7.25%
29,686 $2.06 Million
Q2 2020

Aug 13, 2020

SELL
$58.54 - $67.94 $80,199 - $93,077
-1,370 Reduced 4.1%
32,008 $2.1 Million
Q1 2020

May 11, 2020

SELL
$49.46 - $64.78 $61,825 - $80,975
-1,250 Reduced 3.61%
33,378 $2.01 Million
Q4 2019

Feb 12, 2020

SELL
$49.86 - $58.26 $261,765 - $305,865
-5,250 Reduced 13.17%
34,628 $2 Million
Q3 2019

Nov 13, 2019

BUY
$47.54 - $53.43 $1.66 Million - $1.87 Million
35,000 Added 717.51%
39,878 $2.06 Million
Q1 2019

May 06, 2019

SELL
$46.36 - $52.63 $19,053 - $21,630
-411 Reduced 7.77%
4,878 $255,000
Q4 2018

Feb 08, 2019

SELL
$41.54 - $47.25 $39,961 - $45,454
-962 Reduced 15.39%
5,289 $244,000
Q3 2018

Nov 13, 2018

SELL
$46.76 - $51.24 $142,430 - $156,077
-3,046 Reduced 32.76%
6,251 $295,000
Q2 2018

Dec 21, 2018

BUY
$44.29 - $50.42 $9,433 - $10,739
213 Added 2.34%
9,297 $429,000
Q2 2018

Aug 09, 2018

SELL
$44.29 - $50.42 $57,178 - $65,092
-1,291 Reduced 12.44%
9,084 $419,000
Q1 2018

Dec 21, 2018

BUY
$48.49 - $58.14 $7,855 - $9,418
162 Added 1.59%
10,375 $511,000
Q1 2018

May 15, 2018

BUY
$48.49 - $58.14 $6,303 - $7,558
130 Added 1.29%
10,213 $503,000
Q3 2017

Nov 14, 2017

SELL
$41.15 - $49.22 $40,615 - $48,580
-987 Reduced 8.92%
10,083 $485,000
Q2 2017

Aug 14, 2017

BUY
N/A
11,070
11,070 $475,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $297B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cpwm, LLC Portfolio

Follow Cpwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cpwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cpwm, LLC with notifications on news.